#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mucopolysaccharidosis III Small intestine neuroendocrine tumour Malformation venous B-cell type acute leukaemia Oesophageal squamous cell carcinoma stage II Breast cancer metastatic Essential thrombocythaemia Immunoglobulin G4 related disease Congenital absence of bile ducts PIK3CA-activated mutation Marginal zone lymphoma Meningococcal immunisation Penile cancer Immune-mediated myasthenia gravis Vulval cancer recurrent More trials…

    Learn about Rare Diseases

    Angelman’s syndrome – Basic Information Alternating hemiplegia of childhood – Trials in Disease Optic glioma – Basic Information Haemophilia B without inhibitors – Treatment Methylmalonic acidaemia Usher’s syndrome – Life with Disease Testicular leiomyosarcoma – Diagnostics Breast angiosarcoma metastatic – Diagnostics Hepatoblastoma – Basic Information Fabry’s disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Setmelanotide Pentixather Atorvastatin Emapalumab Mirvetuximab Soravtansine 68Ganota-Anti-Her2 Vhh1 Varegacestat Palivizumab Pf-06480605 Zanidatamab Ibuprofen Obeticholic Acid TRONTINEMAB Sulfasalazine Levofloxacin Rifabutin Sodium Hyaluronate Bi 1015550 Ruzasvir Anthoxanthum Odoratum More therapies…

    Learn about Your Condition

    Aneurysm ruptured Leukoencephalopathy Primary hypercholesterolaemia CADASIL Colorectal cancer stage III Low cardiac output syndrome Bacterial vaginosis Oxygen therapy Depression Bile acid synthesis disorder Chronic myeloid leukaemia Ovarian cancer stage IV Aortic aneurysm Epicondylitis Testis cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Venasum s.r.o.

Venasum s.r.o.

Veľkomoravská 2867/21, Trencin, 911 05, Slovakia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Allo-APZ2-CVU for Patients with Long-Term, Non-Healing Venous Leg Ulcers

    Not recruiting

    3 1
    Investigated Drugs:
    • Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells
    Austria Czechia France Germany Hungary Italy +4

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!